Back
Top 13%
10.9%
Top 46%
5.9%
Top 77%
5.9%
Top 19%
5.9%
Top 2%
4.6%
Top 14%
3.6%
#1
2.8%
Top 2%
2.6%
Top 3%
1.8%
Top 6%
1.8%
Top 11%
1.8%
Top 10%
1.8%
Top 2%
1.4%
Top 3%
1.4%
Top 12%
1.2%
Top 22%
1.2%
Top 16%
1.1%
Top 4%
0.9%
Top 1%
0.9%
Top 4%
0.9%
Top 25%
0.7%
Top 23%
0.7%
Top 16%
0.7%
Top 7%
0.7%
Omitting biopsy in PI-RADS 3? The role of Stockholm3 and PSA density-findings from a prospective Swiss non-referral cohort
2026-01-15
urology
Title + abstract only
View on medRxiv
Show abstract
IntroductionPI-RADS 3 ( equivocal) prostate MRI lesions pose a diagnostic challenge, particularly in non-referral settings with variable MRI quality. We evaluated whether prostate-specific antigen density (PSAD) and the Stockholm3 blood test can aid biopsy decisions for men with PI-RADS 3 lesions in a prospective, non-referral Swiss cohort. MethodsRetrospective analysis of a prospective registry at a non-referral urology practice in Switzerland. From 2023-2025, men with PSA >1.5 ng/mL or suspic...
Predicted journal destinations
1
BMJ Open
553 training papers
2
Scientific Reports
701 training papers
3
PLOS ONE
1737 training papers
4
Nature Communications
483 training papers
5
Cureus
64 training papers
6
eLife
262 training papers
7
Journal of Translational Medicine
21 training papers
8
British Journal of Cancer
22 training papers
9
Cancer Medicine
17 training papers
10
Cancers
57 training papers
11
JAMA Network Open
125 training papers
12
Frontiers in Medicine
99 training papers
13
Diagnostics
36 training papers
14
Journal of Clinical Investigation
50 training papers
15
PLOS Medicine
95 training papers
16
BMC Medicine
155 training papers
17
npj Digital Medicine
85 training papers
18
Clinical Cancer Research
22 training papers
19
Journal of the American Society of Nephrology
19 training papers
20
Science Translational Medicine
40 training papers
21
Journal of Clinical Medicine
77 training papers
22
Nature Medicine
88 training papers
23
eBioMedicine
82 training papers
24
Frontiers in Oncology
34 training papers